P-148 - PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING CHARACTERIZES THE INTERACTION POTENTIAL BETWEEN IMMUNOGLOBULIN AND MONOCLONAL ANTIBODIES IN PRIMARY HUMAN IMMUNODEFICIENCY PATIENTS.
S. Salerno1, R. Deng2,1, T. Kakkar1; 1Gilead Sciences, Inc., Foster City, CA, USA, 2R&D Q-Pharm Consulting LLC, Pleasanton, CA, USA.
.png)